Rudi Pauwels

Rudi Pauwels is the founder of Biocartis Group NV (founded in 2007), Galapagos NV (founded in 1999), Virco Group NV (founded in 1995), and Galapagos Genomics NV (founded in 1999).
He held the title of Non-Executive Director at Biocartis Group NV from 2015 to 2018, Non-Executive Director at Galapagos NV from 2009 to 2010, and Chairman & Chief Scientific Officer at Virco Group NV from 1995 to 2002.
He was also the Chairman of Galapagos Genomics NV in 2002.
Dr. Pauwels is also the founder of Tibotec Virco NV.
Dr. Pauwels currently holds the position of Executive Chairman & Chief Executive Officer at Biocartis SA (since 2013).
He is also the Chairman of Benaruca SA, Executive Chairman & Partner at ANeuroTech BV, Director at Valetusan Ltd., Director at Cambenes SA, Director at Riverwells Investments SA, Director at Calimontes SL, Director at Caruso Inversiones SL, and Member of the Investment Committee at Smile Invest Management Co. NV.
Dr. Pauwels previously held the position of Chairman at RespiVert Ltd. He was an Independent Director at MDxHealth SA from 2013 to 2015.
He also served as a Director at MyCartis NV.
Additionally, he was a Venture Partner at Advent Venture Partners LLP from 2007 to 2011.
Dr. Pauwels obtained a doctorate degree from Katholieke Universiteit Leuven.